Abstract ID: 3233

Primary Topic: Health Services Research/Cost Effectiveness
Secondary Topic: Integrative medicine delivery models

Integrative oncology: international perspectives.
Jennifer Hunter, PhD, MScPH, BMed, Western Sydney University, Sydney, Australia; Jun J Mao, MD, MSCE, Memorial Sloan Kettering, New York, NY, United States; Elio G Rossi, MD, Local Health Unit Tuscany North West of the Region of Tuscany, Lucca, Italy; Dugald Seely, ND. MSc, Ottawa Integrative Cancer Centre, Ottawa, ON, Canada; Suzaane Grant, PhD, MPS, BAppSc, BA, University of Western Sydney, Sydney, Australia

Late Breaker: No


Integrative oncology (IO) is a new evidence-based specialty that integrates traditional and complementary medicine with conventional cancer care. IO acknowledges the increasing role that cancer survivors have in managing their own care, and the importance of a therapeutic alliance that respects the preferences and values of cancer survivors. Increasingly, IO services are being provided by public and private health sectors across the globe. Often however, service development is ad-hoc and fragmented, reflecting local factors rather than coordinated regional or national planning and policy.

In this symposium, leading healthcare professionals and researchers from three continents (North America, Western Europe and Australia) will present an overview of the extent of IO service provision and its implications for clinical practice, health service delivery, education and research. Financial, informational, cultural and logistical barriers and solutions, will be discussed from the perspectives cancer survivors, healthcare professionals, organizations and policy makers.


This symposium will bring together leading healthcare professionals and researchers from across the globe to discuss the development of integrative oncology services and its implications for clinical practice, health service delivery, education, research and policy.


1. Disseminate experience and knowledge from the different countries and continents to identify mutual trends and future directions for IO service provision.
2. Gain insight into unmet needs, and facilitators and barriers for IO.
3. Obtain knowledge about organizational and educational aspects, strategies and policies to support the appropriate development of IO services.

Methods/Session Format

The session will be chaired by Dr Jennifer Hunter. Four speakers will present an overview of IO services within their country or continent (see outline section). Each presenter will have up to 15 minutes for their presentation that will be followed by a 30-minute open panel discussion with the audience.

Suggested symposium time: 90 minutes.

Background information about each speaker and their relevant expertise:                                                                                                           

Jennifer Hunter (Chair), PhD, MScPH, BMed, has over 20 years clinical experience as an integrative medicine, primary care physician. She is a health services researcher at NICM, Western Sydney University and the Menzies Centre for Health Policy, University of Sydney, Australia; and a board member of the Australasian Integrative Medicine Association. Dr Hunter was a chief investigator on the most comprehensive Australia-wide survey of specialized cancer services, titled 'Integrative Oncology in Australia 2016'. She has published extensively on integrative medicine service development and evaluation, and healthcare decision-making.

Jun J. Mao MD, MSCE, is an integrative medicine specialist, board-certified family physician, and licensed acupuncturist who is dedicated to the health and well-being of people with cancer. Dr. Mao is the Chief of Integrative Medicine Service at the Memorial Sloan Kettering Cancer Center, New York and current President of the Society for Integrative Oncology. Dr. Mao’s research has been funded by National Cancer Institute, National Center for Complementary and Integrative Health, American Cancer Society, and Patient-Centered Outcomes Research Institute. He has more than 80 peer-reviewed publications in leading oncology journals.

Elio G. Rossi, MD, is a medical doctor and director of the Coordination Center for Complementary Medicine, Local Health Unit Tuscany North West; the Homeopathic Clinic, Hospital of Lucca - Regional center of reference for homeopathy; and the “Complementary Medicine and diet in oncology” clinic at the Hospital Campo di Marte, Lucca, Italy. Dr Rossi has served on many national and international bodies, including the Health General Direzione of Tuscany Region; the Tuscany Region delegation of the Inter-regional Group "Complementary Medicine"; co-president of the European Congress for Integrative Medicine; and the Tuscan Network for Integrative Medicine. Dr Rossi was the lead scientist for the Tuscan Region of the chapter “Complementary and alternative medicine in cancer care”, WP7 “Healthcare”, European Partnership for Action Against Cancer (EPAAC) where he lead the EPAAC integrative oncology survey of health services operating within European national health systems.

Dugald Seely, ND, MSc is a naturopathic doctor and researcher. Dr Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC), providing a contemporary cancer treatment model based on scientifically grounded, evidence-informed complementary medicine. He is executive director of research & clinical epidemiology at the Canadian College of Naturopathic Medicine, is an affiliate investigator for the Ottawa Hospital Research Institute and is the vice president for the Oncology Association of Naturopathic Physicians (OncANP). Dr Seely has led numerous research projects and most recently secured funding for the largest integrative naturopathic cancer care clinical trial ever conducted in North America. Dr Seely is the recipient of the 2017 Dr Rogers Prize for excellence in Complementary and Alternative Medicine.

Suzanne Grant, PhD, MPS, BAppSc, BA, is currently investigating options and outcomes in integrative oncology at NICM, Western Sydney University and the Chris O’Brien Lifehouse, Sydney, Australia (a world-class not-for-profit integrated cancer treatment centre and tertiary teaching hospital) where she also works as a senior acupuncturist. Dr Grant was a coinvestigator on a national study - Integrative Oncology in Australia 2016. Her research and clinical interests include the effect of Chinese herbal medicine and acupuncture in the treatment of chronic disease. Dr Grant has lectures and publishes widely on these topics.



1. Integrative Oncology in North America, Western Europe and Australia.
2. Current practices, models and policies for Integrative Oncology services in the respective continents and countries.
3. Important unmet needs and barriers/facilitators for implementation of Integrative Oncology.